About Index Trending news
Analyze
Top 50 Pricing
Cytodyn

Cytodyn

Work at Cytodyn? Add yourself to this profile

Cytodyn

CytoDyn is a biotechnology company focused on the development of new therapiesto combat infections with immune deficiency viruses.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series Undisclosed)
$4,300,000
Post-IPO equity
$33,270,000
Employees

Unknown size

Locations
HQ
Headquarters
GeekWire

Charlie Sheen shows interest in CytoDyn, which just raised $33M to develop 'functional cure' for HIV